マイクロフルイディクスの世界市場:用途別、材料別

◆英語タイトル:Microfluidics Market Size, Share & Trends Analysis Report By Material (Polymer, Glass, Silicon, Metal, Ceramic), By Application (Pharmaceutical, In-Vitro diagnostics), By Region, And Segment Forecasts, 2019 - 2026
◆商品コード:GV9NV069
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2019年6月
◆ページ数:122
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、マイクロフルイディクスの世界市場について調査・分析し、市場動向、用途別(医薬品、体外診断薬(IVD)、医療機器)分析、材料別(ポリマー、ガラス、シリコン、その他)分析、地域別分析、競合分析、推薦事項などを含め次の構成でお届け致します。

・調査手法及び範囲
・エグゼクティブサマリー
・市場動向
・マイクロフルイディクスの世界市場:用途別(医薬品、体外診断薬(IVD)、医療機器)
・マイクロフルイディクスの世界市場:材料別(ポリマー、ガラス、シリコン、その他)
・マイクロフルイディクスの世界市場:地域別
・競合分析
・推薦事項
【レポートの概要】

The global microfluidics market size is expected to reach USD 13.4 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 18.07% during the forecast period. Introduction of improved technology, such as digital microfluidics, which enables on-chip biochemical analysis, is anticipated to fuel the growth.

Industry players are introducing newer sampling technologies to meet the demand for screening a huge number of biological samples. For instance, in November 2017, Dolomite introduced its new droplet-based microfluidics platform named Nadia single cell platform for single cell research.

Moreover, researchers are continuously striving to come up with improved sample droplet production techniques. For instance, Columbia University introduced the picoliter fluid dispensation technology. This lab-on-chip technology could deliver sample volume less than 50 nL. Integrating microfluidics with multiplexed sensing technology allows multiple sample analytical application.

Novel drug delivery systems require administration of the drug in the form of nanoparticles, thereby reducing the onset of action. Devices such as microneedles, pumps, and inhalers are expected to experience fastest growth during the forecasted period.

The market players engage in mergers and acquisitions, partnerships, and collaborations among the competitors for technological advancements. For instance, in July 2017 Fluidigm Corporation and Ascendas Genomics underwent into strategic partnership to develop and commercialize molecular diagnostic systems and assays using microfluidic technologies in China.

Further key findings from the study suggest:

• In Vitro Diagnostic (IVD) segment led the application segment owing to the increasing adoption of microfluidics. Moreover, the leaders in the diagnostics sector, such as Abbott, Roche, and Danaher are encouraging the use of newer microfluidics technologies, such as the monodisperse bubbles/drops

• Polymers held the largest revenue share in 2018. Polymers offer better temperature control than glass. However, silicon material is expected to witness the fastest growth owing to the dominance of point-of-care diagnostics in the microfluidics market. Moreover, growing demand for faster results with minimally invasive tools is expected to further boost the growth

• North America led the market in 2018, attributed to the presence of strong research capital, introduction of improved sample volume screening techniques, and presence of dominant market players

• Asia Pacific is expected to witness the fastest CAGR owing to the increasing aging population, repeated hospital visits, presence of untapped market, and the low cost of labor. These factors have attracted many international players to establish their research laboratories in countries like India and China

• Some key players are Illumina, Inc.; Agilent Technologies; Caliper Life Sciences (acquired by PerkinElmer, Inc.); Cepheid; Danaher Corporation; Life Technologies Corporation (acquired by Thermo Fisher Scientific, Inc.); Bio-Rad Laboratories, Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; and Fluidigm Corporation

【レポートの目次】

Table of Contents

Chapter 1 Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Application
1.1.2 Material
1.1.3 Regional Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Europe
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Application
2.2.2 Material
2.2.3 Region
2.2.4 Competitive Insights
2.3 Market Outlook
Chapter 3 Market Variables, Trends& Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market segmentation
3.2.1 Market Driver Analysis
3.2.1.1 Increasing demand for low volume sample analysis
3.2.1.2 Growing penetration of microfluidics in diagnostics market
3.2.1.3 Introduction of advanced technologies
3.2.2 Market Restraint Analysis
3.2.2.1 High operational cost
3.2.2.2 Interfacing and integration
3.2.2.3 Complex fabrication process
3.3 Penetration & growth prospect mapping
3.4 Microfluidics Market Analysis Tools
3.4.1 PEST – SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4.2 Industry Analysis – Porter’s
3.4.3 Major Delas And Strategic Analysis
3.4.3.1 Joint ventures, mergers and acquisition
3.4.3.2 Licensing & partnerships, technology collaborations
Chapter 4 Microfluidics Market: Application Estimates & Trend Analysis
4.1 Microfluidics market: application movement analysis
4.2 Pharmaceuticals
4.2.1 Pharmaceuticals Market, 2015 – 2026 (USD Million)
4.2.2 Genomics
4.2.2.1 Genomics market, 2015 – 2026 (USD Million)
4.2.3 Proteomics
4.2.3.1 Proteomics market, 2015 – 2026 (USD Million)
4.2.4 Cell based assays and others
4.2.4.1 Cell-based assays and others, market, 2015 – 2026 (USD Million)
4.3 In-vitro Diagnostics (IVD)
4.3.1 IVD Market, 2015 – 2026 (USD Million)
4.3.2 POC
4.3.2.1 POC market, 2015 – 2026 (USD Million)
4.3.3 Clinical
4.3.3.1 Clinical market, 2015 – 2026 (USD Million)
4.3.4 Environmental And Industrial
4.3.4.1 Environmental and industrial market, 2015 – 2026 (USD Million)
4.4 Medical Devices
4.4.1 Medical Devices Market, 2015 – 2026 (USD Million)
Chapter 5 Microfluidics Market: Material Estimates & Trend Analysis
5.1 Microfluidics market: Material movement analysis
5.2 Polymer
5.2.1 Polymer Market, 2015 – 2026 (USD Million)
5.3 Glass
5.3.1 Glass Market, 2015 – 2026 (USD Million)
5.4 Silicon
5.4.1 Silicon Market, 2015 – 2026 (USD Million)
5.5 Others
5.5.1 Others Market, 2015 – 2026 (USD Million)
Chapter 6 Microfluidics Market: Regional Estimates & Trend Analysis
6.1 Microfluidics market share, by region, 2018 & 2026
6.2 North America
6.2.1 North America Microfluidics Market, 2015 – 2026 (USD Million)
6.2.2 U.S
6.2.2.1 U.S microfluidics market, 2015 – 2026 (USD Million)
6.2.3 Canada
6.2.3.1 Canada microfluidics market, 2015 – 2026 (USD Million)
6.3 Europe
6.3.1 Europe Microfluidics Market, 2015 – 2026 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. microfluidics market, 2015 – 2026 (USD Million)
6.3.3 Germany
6.3.3.1 Germany microfluidics market, 2015 – 2026 (USD Million)
6.3.4 France
6.3.4.1 France microfluidics market, 2015 – 2026 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Microfluidics Market, 2015 – 2026 (USD Million)
6.4.2 India
6.4.2.1 India microfluidics market, 2015 – 2026 (USD Million)
6.4.3 China
6.4.3.1 China microfluidics market, 2015 – 2026 (USD Million)
6.4.4 Japan
6.4.4.1 Japan microfluidics market, 2015 – 2026 (USD Million)
6.5 Latin America
6.5.1 Latin America Microfluidics Market, 2015 – 2026 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil microfluidics market, 2015 – 2026 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico microfluidics market, 2015 – 2026 (USD Million)
6.6 MEA
6.6.1 MEA Microfluidics Market, 2015 – 2026 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa microfluidics market, 2015 – 2026 (USD Million)
Chapter 7 Competitive Landscape
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Strategy Framework
7.3 Vendor Landscape
7.3.1 List Of Key Distributors And Channel Partners
7.3.2 Strategy Mapping
7.3.2.1 Partnerships
7.3.2.2 Launch of New Product
7.3.2.3 Merger & Acquisition
7.3.2.4 Geographical Expansion
7.3.2.5 Marketing & Promotions
7.4 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
7.5 Company Profiles
7.5.1 Illumina, Inc.
7.5.1.1 Company overview
7.5.1.2 Financial performance
7.5.1.3 Product benchmarking
7.5.1.4 Strategic initiatives
7.5.1.5 SWOT analysis
7.5.2 Agilent Technologies
7.5.2.1 Company overview
7.5.2.2 Financial performance
7.5.2.3 Product benchmarking
7.5.2.4 Strategic initiatives
7.5.2.5 SWOT analysis
7.5.3 Caliper Life Sciences
7.5.3.1 Company overview
7.5.3.2 Financial performance
7.5.3.3 Product benchmarking
7.5.3.4 Strategic initiatives
7.5.3.5 SWOT analysis
7.5.4 Cepheid
7.5.4.1 Company overview
7.5.4.2 Financial performance
7.5.4.3 Product benchmarking
7.5.4.4 Strategic initiatives
7.5.4.5 SWOT analysis
7.5.5 Danaher Corporation
7.5.5.1 Company overview
7.5.5.2 Financial performance
7.5.5.3 Product benchmarking
7.5.5.4 Strategic initiatives
7.5.5.5 SWOT analysis
7.5.6 Life Technologies Corporation
7.5.6.1 Company overview
7.5.6.2 Financial performance
7.5.6.3 Product benchmarking
7.5.6.4 Strategic initiatives
7.5.6.5 SWOT analysis
7.5.7 Bio-Rad Laboratories, Inc.
7.5.7.1 Company overview
7.5.7.2 Financial performance
7.5.7.3 Product benchmarking
7.5.7.4 Strategic initiatives
7.5.7.5 SWOT analysis
7.5.8 Abbott Laboratories
7.5.8.1 Company overview
7.5.8.2 Financial performance
7.5.8.3 Product benchmarking
7.5.8.4 Strategic initiatives
7.5.8.5 SWOT analysis
7.5.9 F. HOFFMANN-LA ROCHE LTD
7.5.9.1 Company overview
7.5.9.2 Financial performance
7.5.9.3 Product benchmarking
7.5.9.4 Strategic initiatives
7.5.9.5 SWOT analysis
7.5.10 Fluidigm Corporation
7.5.10.1 Company overview
7.5.10.2 Financial performance
7.5.10.3 Product benchmarking
7.5.10.4 Strategic initiatives
7.5.10.5 SWOT analysis
Chapter 8 Recommendations

List of Tables

TABLE 1 Primary interview details: North America
TABLE 2 Primary interview details: Europe
TABLE 3 Primary interview details: APAC
TABLE 4 Primary interview details: Latin America
TABLE 5 Primary interview details: MEA
TABLE 6 List of secondary sources
TABLE 7 List of abbreviation
TABLE 8 Joint ventures, mergers and acquisition
TABLE 9 Licensing & partnerships, technology collaborations
TABLE 10 North America microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 11 North America microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 12 North America pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 13 North America IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 14 North America microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 15 U.S. microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 16 U.S. pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 17 U.S. IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 18 U.S. microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 19 Canada microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 20 Canada pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 21 Canada IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 22 Canada microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 23 Europe microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 24 Europe microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 25 Europe pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 26 Europe IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 27 Europe microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 28 U.K. microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 29 U.K. pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 30 U.K. IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 31 U.K. microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 32 Germany microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 33 Germany pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 34 Germany IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 35 Germany microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 36 France microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 37 France pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 38 France IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 39 France microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 40 Asia Pacific microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 41 Asia Pacific microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 42 Asia Pacific pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 43 Asia Pacific IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 44 Asia Pacific microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 45 India microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 46 India pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 47 India IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 48 India microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 49 China microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 50 China pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 51 China IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 52 China microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 53 Japan microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 54 Japan pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 55 Japan IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 56 Japan microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 57 Latin America microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 58 Latin America microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 59 Latin America pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 60 Latin America IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 61 Latin America microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 62 Brazil microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 63 Brazil pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 64 Brazil IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 65 Brazil microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 66 Mexico microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 67 Mexico pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 68 Mexico IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 69 Mexico microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 70 MEA microfluidics market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 71 MEA microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 72 MEA pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 73 MEA IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 74 MEA microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)
TABLE 75 South Africa microfluidics market estimates and forecasts, by application, 2015 - 2026 (USD Million)
TABLE 76 South Africa pharmaceutical market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 77 South Africa IVD market estimates and forecasts, by type, 2015 - 2026 (USD Million)
TABLE 78 South Africa microfluidics market estimates and forecasts, by material, 2015 - 2026 (USD Million)

【レポートのキーワード】

マイクロフルイディクス、医薬品、体外診断薬(IVD)、医療機器、ポリマー、ガラス、シリコン

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[マイクロフルイディクスの世界市場:用途別、材料別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆